Equity Overview
Price & Market Data
Price: $50.14
Daily Change: $0.00 / 0.00%
Daily Range: $50.14 - $50.14
Market Cap: $3,559,233,280
Daily Volume: 150
Performance Metrics
1 Week: -4.98%
1 Month: -15.82%
3 Months: -22.12%
6 Months: -50.45%
1 Year: -60.06%
YTD: -49.71%
Company Details
Employees: 335
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States. The company has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. It also provides Zegalogue, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon for treating congenital hyperinsulinism. In addition, the company developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. Zealand Pharma A/S was incorporated in 1997 and is based in Søborg, Denmark.